시장보고서
상품코드
1149051

세계의 약물 방출용 풍선 카테터 시장 규모 : 제품별, 최종 용도별, 업계 분석, 지역 전망, 성장 가능성, 경쟁 시장 점유율, 예측(2022-2030년)

Drug-Eluting Balloon Catheters Market Size By Product, By End-use Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 - 2030

발행일: | 리서치사: Global Market Insights Inc. | 페이지 정보: 영문 159 Pages | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 약물 방출용 풍선 카테터 시장 규모는 노인 인구 증가로 2030년 상당한 성장을 기록할 것으로 예상됩니다.

또한 의료기기 분야 기술 진보도 업계를 성장시킬 것으로 예측됩니다.

세계의 약물 방출용 풍선 카테터(Drug-Eluting Balloon Catheters) 시장 조사 분석을 통해 업계 고려 사항, 부문 분석, 지역 분석, 기업 프로필 등을 제공합니다.

목차

제1장 조사 방법

제2장 주요 요약

제3장 약물 방출용 풍선 카테터 업계 고찰

  • 업계 세분화
  • 업계 정세(2017-2030년)
  • 업계 영향 요인
    • 성장 촉진 요인
    • 업계 잠재 리스크·과제
  • 성장 가능성 분석
    • 제품별
    • 최종 용도별
  • COVID-19 영향 분석
  • 포터의 5가지 경쟁요인 분석
  • 경쟁 상황(2021년)
    • 기업 매트릭스 분석(2021년)
  • PESTEL 분석

제4장 약물 방출용 풍선 카테터 시장 : 제품별

  • 주요 부문 동향
  • 관상 동맥 질환용 약물 방출용 풍선 카테터
    • 시장 규모 : 지역별(2017-2030년)
    • 파클리탁셀
    • 시롤리무스
  • 말초 혈관 질환용 약물 방출용 풍선 카테터
    • 시장 규모 : 지역별(2017-2030년)
    • 시롤리무스

제5장 약물 방출용 풍선 카테터 시장 : 최종 용도별

  • 주요 부문 동향
  • 병원·진료소
  • 외래 수술 센터
  • 카테터 검사실

제6장 약물 방출용 풍선 카테터 시장 : 지역별

  • 주요 지역 동향
  • 북미
    • 시장 규모 : 국가별(2017-2030년)
    • 시장 규모 : 제품별(2017-2030년)
    • 시장 규모 : 최종 용도별(2017-2030년)
    • 미국
    • 캐나다
  • 유럽
    • 시장 규모 : 국가별(2017-2030년)
    • 시장 규모 : 제품별(2017-2030년)
    • 시장 규모 : 최종 용도별(2017-2030년)
    • 독일
    • 영국
    • 프랑스
    • 이탈리아
    • 스페인
  • 아시아태평양
    • 시장 규모 : 국가별(2017-2030년)
    • 시장 규모 : 제품별(2017-2030년)
    • 시장 규모 : 최종 용도별(2017-2030년)
    • 중국
    • 일본
    • 인도
    • 호주
    • 한국
  • 라틴아메리카
    • 시장 규모 : 국가별(2017-2030년)
    • 시장 규모 : 제품별(2017-2030년)
    • 시장 규모 : 최종 용도별(2017-2030년)
    • 브라질
    • 멕시코
    • 아르헨티나
  • 중동·아프리카
    • 시장 규모 : 국가별(2017-2030년)
    • 시장 규모 : 제품별(2017-2030년)
    • 시장 규모 : 최종 용도별(2017-2030년)
    • 남아프리카
    • 사우디 아라비아
    • 아랍에미리트 연방

제7장 기업 프로필

  • 경쟁 대시보드(2021년)
  • Aachen Resonance GmbH
  • B. Braun Melsungen AG
  • BD Interventional
  • Biosensors International
  • Biotronik AG
  • Boston Scientific Corporation
  • Eurocor GmbH
  • iVascular SLU
  • Zhejiang Barty Medical Technology Co.Ltd
  • Lepu Medical Technology(Beijing) Co. Ltd.
  • MedAlliance
  • Medtronic
NJH 22.11.15

The global drug-eluting balloon catheters market is anticipated to register considerable gains through 2030, driven by rising geriatric population. Meanwhile, increasing technological advancements in the field of medical devices is also projected to shape industry growth.

Back in March 2021, MedAlliance obtained U.S. FDA approval for its breakthrough device called Sirolimus drug-eluting balloon catheter. This gave patients across the U.S. faster access to the firm's innovative 90-day sirolimus release tech, which holds the potential to deliver safe and more effective treatment.

DCB catheters ensure a homogenous drug release to the vessel wall for immediate drug delivery, reduce restenosis rates, and help treat peripheral as well as arterial diseases in a minimally invasive manner.

High prices associated with DCB catheter-based treatments may constrain industry outlook. The coronary paclitaxel balloon catheters cost around USD 3,500, which brings them out of the reach of many patients. However, with many nations putting efforts towards attaining universal health coverage (UHC) through strengthening of health systems and introduction of robust financing structures, the impact of high prices is likely to be dampened in coming years.

The global drug-eluting balloon catheters market landscape is bifurcated into different segments such as product, end-use, and regional outlook.

On the basis of product, the industry is categorized into coronary artery disease DCB catheters and peripheral vascular disease DCB catheters. Amongst them, the peripheral vascular disease drug-coated balloon catheters are expected to witness substantial gains, fueled by their efficacy in drug release and increasing cases of peripheral disorders. Peripheral vascular disease DCB catheters help prevent restenosis, which ensures patient safety during surgeries.

With respect to end-use, the industry is classified into ambulatory surgical centers, hospitals and clinics, and catheterization laboratories. The market is slated to witness surging demand from the hospitals and clinics segment owing to increasing cases of cardiovascular diseases and rising hospital admissions for the treatment of such heart-related ailments.

Apart from CVDs, peripheral artery diseases are also some of the prominent ailments contributing towards hospitalizations for catheterization. The presence of a favorable clinical environment across hospitals and clinics and availability of more sophisticated equipment is also influencing segment growth.

From the regional viewpoint, the market is classified into North America, Asia Pacific, Europe, Latin America, and MEA. The Latin America drug-eluting balloon catheters industry is anticipated to expand at a notable rate, owing to the rising prevalence of cardiovascular diseases (CVDs) in the region. CVDs are considered one of the leading causes of deaths across LATAM, responsible for over a million deaths annually. Stroke and coronary heart disease account for 28.8% and 42.5% of cardiovascular disease mortality in the region, respectively.

Table of Contents

Chapter 1 Methodology

  • 1.1 Market definitions
  • 1.2 Base estimates & working
  • 1.3 Forecast parameters
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 Drug-eluting balloon catheters industry 360 degree synopsis, 2017 - 2030
    • 2.1.1 Business trends
    • 2.1.2 Product trends
    • 2.1.3 End-use trends
    • 2.1.4 Regional trends

Chapter 3 Drug-Eluting Balloon Catheters Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2017 - 2030 (USD Million)
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Growing prevalence of peripheral and cardiovascular diseases
      • 3.3.1.2 Technological advancements in drug-eluting balloon catheters
      • 3.3.1.3 Increasing preference for minimally invasive procedures
      • 3.3.1.4 Rising geriatric population globally
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 High cost of product
      • 3.3.2.2 Risk of infection associated with the use of drug-eluting balloon catheters
  • 3.4 Growth potential analysis
    • 3.4.1 By product
    • 3.4.2 By end-use
  • 3.5 COVID-19 impact analysis
  • 3.6 Porter's analysis
  • 3.7 Competitive landscape, 2021
    • 3.7.1 Company matrix analysis, 2021
  • 3.8 PESTEL analysis

Chapter 4 Drug-Eluting Balloon Catheters Market, By Product

  • 4.1 Key segment trends
  • 4.2 Coronary artery disease drug-eluting balloon catheters
    • 4.2.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.2.2 Paclitaxel
      • 4.2.2.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.2.3 Sirolimus
      • 4.2.3.1 Market size, by region, 2017 - 2030 (USD Million)
  • 4.3 Peripheral vascular disease drug-eluting balloon catheters
    • 4.3.1 Market size, by region, 2017 - 2030 (USD Million)
      • 4.3.1.2 Paclitaxel
        • 4.3.1.2.1 Market size, by region, 2017 - 2030 (USD Million)
    • 4.3.2 Sirolimus
      • 4.3.2.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 5 Drug-Eluting Balloon Catheters Market, By End-use

  • 5.1 Key segment trends
  • 5.2 Hospitals and clinics
    • 5.2.1 Market size, by region, 2017 - 2030 (USD Million)
  • 5.3 Ambulatory surgical centers
    • 5.3.1 Market size, by region, 2017 - 2030 (USD Million)
  • 5.4 Catheterization laboratories
    • 5.4.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 6 Drug-Eluting Balloon Catheters Market, By Region

  • 6.1 Key regional trends
  • 6.2 North America
    • 6.2.1 Market size, by country, 2017 - 2030 (USD Million)
    • 6.2.2 Market size, by product, 2017 - 2030 (USD Million)
      • 6.2.2.1 Market size, by coronary artery disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
      • 6.2.2.2 Market size, by peripheral vascular disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
    • 6.2.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 6.2.4 U.S.
      • 6.2.4.1 Market size, by product, 2017 - 2030 (USD Million)
        • 6.2.4.1.1 Market size, by coronary artery disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
        • 6.2.4.1.2 Market size, by peripheral vascular disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
      • 6.2.4.2 Market size, by end-use, 2017 - 2030 (USD Million)
    • 6.2.5 Canada
      • 6.2.5.1 Market size, by product, 2017 - 2030 (USD Million)
        • 6.2.5.1.1 Market size, by coronary artery disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
        • 6.2.5.1.2 Market size, by peripheral vascular disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
      • 6.2.5.2 Market size, by end-use, 2017 - 2030 (USD Million)
  • 6.3 Europe
    • 6.3.1 Market size, by country, 2017 - 2030 (USD Million)
    • 6.3.2 Market size, by product, 2017 - 2030 (USD Million)
      • 6.3.2.1 Market size, by coronary artery disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
      • 6.3.2.2 Market size, by peripheral vascular disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
    • 6.3.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 6.3.4 Germany
      • 6.3.4.1 Market size, by product, 2017 - 2030 (USD Million)
        • 6.3.4.1.1 Market size, by coronary artery disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
        • 6.3.4.1.2 Market size, by peripheral vascular disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
      • 6.3.4.2 Market size, by end-use, 2017 - 2030 (USD Million)
    • 6.3.5 UK
      • 6.3.5.1 Market size, by product, 2017 - 2030 (USD Million)
        • 6.3.5.1.1 Market size, by coronary artery disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
        • 6.3.5.1.2 Market size, by peripheral vascular disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
      • 6.3.5.2 Market size, by end-use, 2017 - 2030 (USD Million)
    • 6.3.6 France
      • 6.3.6.1 Market size, by product, 2017 - 2030 (USD Million)
        • 6.3.6.1.1 Market size, by coronary artery disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
        • 6.3.6.1.2 Market size, by peripheral vascular disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
      • 6.3.6.2 Market size, by end-use, 2017 - 2030 (USD Million)
    • 6.3.7 Italy
      • 6.3.7.1 Market size, by product, 2017 - 2030 (USD Million)
        • 6.3.7.1.1 Market size, by coronary artery disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
        • 6.3.7.1.2 Market size, by peripheral vascular disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
      • 6.3.7.2 Market size, by end-use, 2017 - 2030 (USD Million)
    • 6.3.8 Spain
      • 6.3.8.1 Market size, by product, 2017 - 2030 (USD Million)
        • 6.3.8.1.1 Market size, by coronary artery disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
        • 6.3.8.1.2 Market size, by peripheral vascular disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
      • 6.3.8.2 Market size, by end-use, 2017 - 2030 (USD Million)
  • 6.4 Asia Pacific
    • 6.4.1 Market size, by country, 2017 - 2030 (USD Million)
    • 6.4.2 Market size, by product, 2017 - 2030 (USD Million)
      • 6.4.2.1 Market size, by coronary artery disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
      • 6.4.2.2 Market size, by peripheral vascular disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
    • 6.4.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 6.4.4 China
      • 6.4.4.1 Market size, by product, 2017 - 2030 (USD Million)
        • 6.4.4.1.1 Market size, by coronary artery disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
        • 6.4.4.1.2 Market size, by peripheral vascular disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
      • 6.4.4.2 Market size, by end-use, 2017 - 2030 (USD Million)
    • 6.4.5 Japan
      • 6.4.5.1 Market size, by product, 2017 - 2030 (USD Million)
        • 6.4.5.1.1 Market size, by coronary artery disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
        • 6.4.5.1.2 Market size, by peripheral vascular disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
      • 6.4.5.2 Market size, by end-use, 2017 - 2030 (USD Million)
    • 6.4.6 India
      • 6.4.6.1 Market size, by product, 2017 - 2030 (USD Million)
        • 6.4.6.1.1 Market size, by coronary artery disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
        • 6.4.6.1.2 Market size, by peripheral vascular disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
      • 6.4.6.2 Market size, by end-use, 2017 - 2030 (USD Million)
    • 6.4.7 Australia
      • 6.4.7.1 Market size, by product, 2017 - 2030 (USD Million)
        • 6.4.7.1.1 Market size, by coronary artery disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
        • 6.4.7.1.2 Market size, by peripheral vascular disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
      • 6.4.7.2 Market size, by end-use, 2017 - 2030 (USD Million)
    • 6.4.8 South Korea
      • 6.4.8.1 Market size, by product, 2017 - 2030 (USD Million)
        • 6.4.8.1.1 Market size, by coronary artery disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
        • 6.4.8.1.2 Market size, by peripheral vascular disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
      • 6.4.8.2 Market size, by end-use, 2017 - 2030 (USD Million)
  • 6.5 Latin America
    • 6.5.1 Market size, by country, 2017 - 2030 (USD Million)
    • 6.5.2 Market size, by product, 2017 - 2030 (USD Million)
      • 6.5.2.1 Market size, by coronary artery disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
      • 6.5.2.2 Market size, by peripheral vascular disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
    • 6.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 6.5.4 Brazil
      • 6.5.4.1 Market size, by product, 2017 - 2030 (USD Million)
        • 6.5.4.1.1 Market size, by coronary artery disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
        • 6.5.4.1.2 Market size, by peripheral vascular disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
      • 6.5.4.2 Market size, by end-use, 2017 - 2030 (USD Million)
    • 6.5.5 Mexico
      • 6.5.5.1 Market size, by product, 2017 - 2030 (USD Million)
        • 6.5.5.1.1 Market size, by coronary artery disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
        • 6.5.5.1.2 Market size, by peripheral vascular disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
      • 6.5.5.2 Market size, by end-use, 2017 - 2030 (USD Million)
    • 6.5.6 Argentina
      • 6.5.6.1 Market size, by product, 2017 - 2030 (USD Million)
        • 6.5.6.1.1 Market size, by coronary artery disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
        • 6.5.6.1.2 Market size, by peripheral vascular disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
      • 6.5.6.2 Market size, by end-use, 2017 - 2030 (USD Million)
  • 6.6 Middle East and Africa
    • 6.6.1 Market size, by country, 2017 - 2030 (USD Million)
    • 6.6.2 Market size, by product, 2017 - 2030 (USD Million)
      • 6.6.2.1 Market size, by coronary artery disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
      • 6.6.2.2 Market size, by peripheral vascular disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
    • 6.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 6.6.4 South Africa
      • 6.6.4.1 Market size, by product, 2017 - 2030 (USD Million)
        • 6.6.4.1.1 Market size, by coronary artery disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
        • 6.6.4.1.2 Market size, by peripheral vascular disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
      • 6.6.4.2 Market size, by end-use, 2017 - 2030 (USD Million)
    • 6.6.5 Saudi Arabia
      • 6.6.5.1 Market size, by product, 2017 - 2030 (USD Million)
        • 6.6.5.1.1 Market size, by coronary artery disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
        • 6.6.5.1.2 Market size, by peripheral vascular disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
      • 6.6.5.2 Market size, by end-use, 2017 - 2030 (USD Million)
    • 6.6.6 UAE
      • 6.6.6.1 Market size, by product, 2017 - 2030 (USD Million)
        • 6.6.6.1.1 Market size, by coronary artery disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
        • 6.6.6.1.2 Market size, by peripheral vascular disease drug-eluting balloon catheters, 2017 - 2030 (USD Million)
      • 6.6.6.2 Market size, by end-use, 2017 - 2030 (USD Million)

Chapter 7 Company Profiles

  • 7.1 Competitive dashboard, 2021
  • 7.2 Aachen Resonance GmbH
    • 7.2.1 Business overview
    • 7.2.2 Financial data
    • 7.2.3 Product landscape
    • 7.2.4 Strategic outlook
    • 7.2.5 SWOT analysis
  • 7.3 B. Braun Melsungen AG
    • 7.3.1 Business overview
    • 7.3.2 Financial data
    • 7.3.3 Product landscape
    • 7.3.4 Strategic outlook
    • 7.3.5 SWOT analysis
  • 7.4 BD Interventional
    • 7.4.1 Business overview
    • 7.4.2 Financial data
    • 7.4.3 Product landscape
    • 7.4.4 Strategic outlook
    • 7.4.5 SWOT analysis
  • 7.5 Biosensors International
    • 7.5.1 Business overview
    • 7.5.2 Financial data
    • 7.5.3 Product landscape
    • 7.5.4 Strategic outlook
    • 7.5.5 SWOT analysis
  • 7.6 Biotronik AG
    • 7.6.1 Business overview
    • 7.6.2 Financial data
    • 7.6.3 Product landscape
    • 7.6.4 Strategic outlook
    • 7.6.5 SWOT analysis
  • 7.7 Boston Scientific Corporation
    • 7.7.1 Business overview
    • 7.7.2 Financial data
    • 7.7.3 Product landscape
    • 7.7.4 Strategic outlook
    • 7.7.5 SWOT analysis
  • 7.8 Eurocor GmbH
    • 7.8.1 Business overview
    • 7.8.2 Financial data
    • 7.8.3 Product landscape
    • 7.8.4 Strategic outlook
    • 7.8.5 SWOT analysis
  • 7.9 iVascular S.L.U.
    • 7.9.1 Business overview
    • 7.9.2 Financial data
    • 7.9.3 Product landscape
    • 7.9.4 Strategic outlook
    • 7.9.5 SWOT analysis
  • 7.10 Zhejiang Barty Medical Technology Co.Ltd
    • 7.10.1 Business overview
    • 7.10.2 Financial data
    • 7.10.3 Product landscape
    • 7.10.4 Strategic outlook
    • 7.10.5 SWOT analysis
  • 7.11 Lepu Medical Technology(Beijing)Co. Ltd.
    • 7.11.1 Business overview
    • 7.11.2 Financial data
    • 7.11.3 Product landscape
    • 7.11.4 Strategic outlook
    • 7.11.5 SWOT analysis
  • 7.12 MedAlliance
    • 7.12.1 Business overview
    • 7.12.2 Financial data
    • 7.12.3 Product landscape
    • 7.12.4 Strategic outlook
    • 7.12.5 SWOT analysis
  • 7.13 Medtronic
    • 7.13.1 Business overview
    • 7.13.2 Financial data
    • 7.13.3 Product landscape
    • 7.13.4 Strategic outlook
    • 7.13.5 SWOT analysis
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제